DESVENLAFAXINE
- Product NDC
- 50090-7737
- 11-digit product format
- 500907737
- Labeler code
- 50090
- Product ID
- 50090-7737_c70b23a2-7522-4b56-869d-f92abe5b8afd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DESVENLAFAXINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA204028
- Marketing category
- ANDA
- Marketing start
- 2022-01-31
- Substance
- DESVENLAFAXINE SUCCINATE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DESVENLAFAXINE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DESVENLAFAXINE SUCCINATE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ZB22ENF0XR |
| Rxcui | 1874559 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-7737-0 | DESVENLAFAXINE | 30 in 1 PACKAGE | TABLET, EXTENDED RELEASE | 30 | | 7 |
| 50090-7737-1 | DESVENLAFAXINE | 90 in 1 PACKAGE | TABLET, EXTENDED RELEASE | 90 | | 7 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7737-0 | 50090773700 | 30 TABLET, EXTENDED RELEASE in 1 PACKAGE (50090-7737-0) | 2025-10-28 | No | No | Current |
| 50090-7737-1 | 50090773701 | 90 TABLET, EXTENDED RELEASE in 1 PACKAGE (50090-7737-1) | 2025-10-28 | No | No | Current |